🕵️ CUE Biopharma, Inc. ($CUE)
SEC insider & ownership activity, last 12 months · CIK 1645460 · every row links its SEC filing
Insider buy and sell values were withheld pending verification over the last 12 months. No red-flag 8-Ks in the window.
🚨 1 signal active —
planned-vs-executed verdicts, pre-event flags, and cluster context live in the
API and the
alerts bot.
Insider flow
2 buyers, value withheld pending verification (6 lots) · 3 sellers, value withheld pending verification (11 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Ray Sumita | 0 | – | 3 | value withheld pending verification | Aug 13, 2026 |
| Meluzio Michael Vincent | 0 | – | 3 | value withheld pending verification | Aug 13, 2026 |
| Lin Shao-Lee | 1 | value withheld pending verification | 5 | value withheld pending verification | Aug 13, 2026 |
| Sarraf Pasha | 5 | value withheld pending verification | 0 | – | Dec 30, 2025 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Bleichroeder LP | 10.0% | 13G | Mar 21, 2025 | filing ↗ | |
| Bleichroeder Holdings LLC | 10.0% | 13G | Mar 21, 2025 | filing ↗ | |
| Andrew Gundlach | 10.0% | 13G | Mar 21, 2025 | filing ↗ | |
| Driehaus Capital Management LLC | 7.0% | 13G | Aug 14, 2026 | filing ↗ | |
| Shao-Lee Lin | 6.2% | 13D | May 3, 2026 | filing ↗ |
Planned insider sales (Form 144)
| Seller | Planned | Approx. sale date | |
|---|---|---|---|
| Shao-Lee Lin | $516K | Aug 13, 2026 | filing ↗ |
| Sumita Ray | $266K | Aug 13, 2026 | filing ↗ |
| Shao-Lee Lin | $1.1M | Aug 12, 2026 | filing ↗ |
| Matteo Giacomo Levisetti | $2K | Dec 29, 2025 | filing ↗ |
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Earnings (2.02) | Aug 14, 2026 | filing ↗ |
| Officer/director changes (5.02) | Jul 27, 2026 | filing ↗ |
| Material agreement (1.01) | Jul 9, 2026 | filing ↗ |
| Unregistered equity sale (3.02) | Jul 9, 2026 | filing ↗ |
| Officer/director changes (5.02) | Jul 9, 2026 | filing ↗ |
| Other events (8.01) | Jul 9, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jul 9, 2026 | filing ↗ |
| Officer/director changes (5.02) | Jun 1, 2026 | filing ↗ |
| Shareholder vote (5.07) | Jun 1, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 1, 2026 | filing ↗ |
| Officer/director changes (5.02) | May 29, 2026 | filing ↗ |
| Other events (8.01) | May 29, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 14, 2026 | filing ↗ |
| Material agreement (1.01) | Apr 27, 2026 | filing ↗ |
| Unregistered equity sale (3.02) | Apr 27, 2026 | filing ↗ |
| Officer/director changes (5.02) | Apr 27, 2026 | filing ↗ |
| Other events (8.01) | Apr 27, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Apr 27, 2026 | filing ↗ |
| Material Modifications to Rights of Security Holders (3.03) | Apr 22, 2026 | filing ↗ |
| Charter/bylaw changes (5.03) | Apr 22, 2026 | filing ↗ |
| Shareholder vote (5.07) | Apr 13, 2026 | filing ↗ |
| Other events (8.01) | Apr 1, 2026 | filing ↗ |
| Officer/director changes (5.02) | Mar 23, 2026 | filing ↗ |
| Earnings (2.02) | Mar 16, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 16, 2026 | filing ↗ |
| Other events (8.01) | Feb 18, 2026 | filing ↗ |
| Officer/director changes (5.02) | Feb 9, 2026 | filing ↗ |
| Material agreement (1.01) | Dec 19, 2025 | filing ↗ |
| Other events (8.01) | Dec 19, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Dec 19, 2025 | filing ↗ |